NewsRamp Health & Wellness Podcast

Soligenix's HyBryte shows promise for cutaneous T-cell lymphoma, NurExone Biologic wins award and plans investor outreach, CIRM celebrates FDA approval of KRESLADI™, GeoVax Labs' MVA-X vaccine offers durable protection, and Sigyn Therapeutics evaluates technologies for CTE in former NFL players.

Discover advancements in precision cardiovascular medicine, cancer treatment, rare disease therapies, and preventive oral care. Explore transformative technologies, clinical trials, financial milestones, and strategic partnerships in the biotech and healthcare sectors.

A $20M initiative targets single ventricle heart disease care, a pharmacy professional partners with CMP, thymus impacts cancer immunotherapy, companies announce financial progress, and AI Maverick Intel plans to acquire HEAL Access Canada Inc. SS Innovations expands globally, and the American Heart Association emphasizes the importance of physical activity for heart health.

10X Health appoints Jeff Zwiefel to drive global growth in personalized health solutions, while Ezalife experiences early success with its feeding tube product and equity crowdfunding campaign.

Forian Inc. sees revenue growth, Lixte Biotech advances precision oncology, Aptevo's mipletamig shows promising results in AML treatment, Ethema Health appoints new CFO, and Sigyn Therapeutics introduces CardioDialysis for cardiovascular disease. Exciting advancements in cancer immunotherapy are also highlighted.

Lantern Pharma's FDA-approved STAR-001 trial targets pediatric CNS cancer, Catalyst Crew Tech launches CardioAI for cardiovascular risk assessment, and RHON-KLINIKUM AG achieves solid financial results in 2025.

Soligenix obtains 10-year exclusivity in EU for Behcet Disease treatment, following positive Phase 2a data, enhancing its rare autoimmune condition focus.

Oragenics discloses audit opinion, Lexaria Bioscience adds 5 new patents, NeuroOne® completes successful limited release of nerve ablation system, and Okogen Inc. acquires intellectual property for ranpirnase to expand ophthalmic program.

HeartBeam collaborates with Mount Sinai to advance AI-ECG technology, proton therapy shows promising results in cancer treatment, Soligenix prepares for key clinical milestones, and Engle Services offers tips for AC breakdowns in Alabama.

VolitionRx shows promising results in early cancer detection, GeoVax Labs progresses towards Phase 3 trial, and AccuRoute and InterFAX offer secure healthcare solutions for regulated industries.

Lantern Pharma and American Shared Hospital Services to discuss financial results; breakthrough discovery supports CardioDialysis for neuroinflammatory diseases; Catalyst Crew Technologies expands into Venezuela for healthcare tech initiatives.

Viromed Medical AG secures funding for cold plasma technology, Soligenix advances rare disease therapies, LIXTE Biotechnology targets cancer treatment improvement, and orthodontic practices offer cutting-edge care.

Jodi Ungrodt, a seasoned financial leader and SEC-Qualified Financial Expert, brings valuable expertise to BioStem Technologies as the new Chair of the Audit Committee. Meanwhile, global tributes honor the legacy of martial arts legend Chuck Norris, highlighting his profound impact on performance and conditioning in the sports nutrition industry.

Co-Diagnostics broadens distribution, while studies reveal links between lifestyle and health outcomes. Soligenix strengthens rare disease pipeline, and innovative therapies in cancer care and oncology are on the rise.

Vesicor Therapeutics appoints Dr. Michael Tolentino as CEO, while founder Dr. Luo Feng becomes CSO. Catalyst Crew Technologies seeks name change to LataMed AI Corp. to reflect focus on AI healthcare tech in Latin America.

Join MEDICLIN's virtual press conference, learn about Soligenix's HyBryte therapy, orthodontic care options in NC and NH, new research on reducing hypertensive disorders in pregnant women, and updates from Aditxt Inc. and Annovis Bio Inc.

Aclarion adopts stockholder rights plan; Soligenix focuses on HyBryte study and rare diseases; NRx Pharmaceuticals schedules conference call; Catalyst Crew introduces AI healthcare analytics platform for Latin America.

Lions Clubs International Foundation awards a grant to expand an eye bank, ETST integrates telehealth services, Rochester housing market prepares for medical influx, a study reveals insights on colorectal cancer, and Soligenix advances rare disease treatments through platform science.

Nutriband, VolitionRx, SS Innovations, Dr. Badia, and research findings on prediabetes and heart failure risks are spotlighted, alongside updates from NRx Pharmaceuticals and Oragenics Inc.

A new study shows promise in cancer treatment using mirror-image amino acids, while a report highlights a 90% failure rate in AI agent security in healthcare. Companies are advancing cancer therapies, but healthcare faces significant risks from unmonitored AI agents.

Scinai faces Nasdaq bid price issue; NeuroOne's OneRF technology aids epilepsy patients; Aclarion discusses Nociscan at ROTH Conference; Okuda Orthodontics offers Invisalign and brace options for all ages in Henderson, NV.

Sartorius introduces Eveo Cell Therapy Platform to boost production; Helix BioPharma faces financial challenges; BioUtah celebrates winners of life sciences pitch competition; HeartBeam revolutionizes cardiac monitoring; LIXTE Biotechnology and Liora Technologies partner to enhance cancer treatment.

Stacey Eisenberg emphasizes community effort in dementia care, Lifespring Chiropractic focuses on natural health education, and Voyageur Pharmaceuticals advances diagnostic imaging supply chain. Aubrey Schwartze wins sports scholarship. Friendly Recovery Center compares therapy options.

Dr. Kixx Goldman questions the impact of labeling in therapy, while attorney Willard Bakeman challenges America's justice system in two new books.

HeartBeam progresses post-FDA clearance, Sigyn Therapeutics explores merger options, gut microbiota's role in cancer treatment, Aditxt's acquisition in oncology, and LIXTE Biotechnology expands cancer trial partnerships.